my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Industrial Sectors
Contact / Request information
Contact the company and request further information free of charge:
Watchlist
This is where you can add this company to your personal favourites
Merck Serono Announces Creation of First Spin-Off Company From Its Entrepreneur Partnership Program
Merck Serono, a division of Merck, Darmstadt, Germany, announced the creation of Prexton Therapeutics, the first spin-off company resulting from its Entrepreneur Partnership Program launched in April 2012. Prexton Therapeutics will be formed around Merck Serono’s R&D portfolio in the field ... more
Merck Announces Merck Serono Implementation Plans for Its Efficiency Program in Switzerland
Merck announced the efficiency measures it plans to take related to Merck Serono’s operations in Switzerland as part of the comprehensive transformation program announced by the company in February. Merck’s transformation program is focused on addressing unprecedented market shifts, increas ... more
Ablynx and Merck Serono select a novel nanobody candidate, ALX-0761, for pre-clinical development
Ablynx and partner Merck Serono announced that they have advanced the Nanobody candidate, ALX-0761, into pre-clinical development for the treatment of autoimmune diseases. This is the first pre-clinical candidate that has emerged from the collaboration which the companies entered in 2008, a ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
